A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B
Clinical trial NCT02053792 · COMPLETED
Trial details
- NCT number
- NCT02053792
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-06
- Primary completion
- 2021-06-02
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.